insights_auto
为什么 SOBI 上涨了 2.39%?
深入探索chevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 437.40
arrow_upward
+2.39%(+10.20) 1 天
10月14日, GMT+2 17:29:59 · SEK
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 SOBI 生成关键数据洞见…
开盘价
SEK 427.40
最高价
SEK 438.00
最低价
SEK 424.80
市值
1564.30亿
平均成交量
25.58万
成交量
36.04万
市盈率
116.82
52 周最高价
SEK 487.00
52 周最低价
SEK 293.60
每股收益
SEK 3.74
流通股数
3.58亿
员工人数
2119
开盘价
SEK 427.40
最高价
SEK 438.00
最低价
SEK 424.80
市值
1564.30亿
平均成交量
25.58万
成交量
36.04万
市盈率
116.82
52 周最高价
SEK 487.00
52 周最低价
SEK 293.60
每股收益
SEK 3.74
流通股数
3.58亿
员工人数
2119
新闻报道
来自网络来源和新闻合作伙伴
CoinDesk
·
17小时前
标普500期权成为该超流动交易所最热门的押注
Traders Union
·
1天前
Ryan Detrick：遵循中期选举年后的市场规律，S&P 500 自 2026 年 3 月 30 日以来上涨约 18%
资料
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Swedish Orphan Biovitrum AB (publ)简介